article thumbnail

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Healthcare IT Today

Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).

BioTech 107
article thumbnail

Biotech billionaire Patrick Soon-Shiong steps down from ONC health IT advisory committee

FierceHealthIT

the biotech billionaire and CEO of health technology company NantWorks, on Wednesday said that he is stepping down from the federal Health IT Advisory Committee (HITAC) that provides policy recommendations to the Office of the National Coordinator for Health IT. Patrick Soon-Shiong, M.D.,

BioTech 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. I anticipate that smaller biotech companies will consider multiple avenues for securing funding, including through SPAC deals similar to the one that we at Abpro announced this year. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Supreme Group Acquires Health+Commerce, an Integrated Marketing and Public Relations Agency Serving Innovative Healthcare Companies

Digital Health Global

Health+Commerce is Supreme Group’s second add-on following its acquisition of Clarity Quest , a health IT marketing agency. We’re thrilled to welcome Health+Commerce to the Supreme Group family of companies,” said Tom Donnelly, CEO, Supreme Group. “In For more information visit www.supremegroup.io.

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.

BioTech 144
article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 110
article thumbnail

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

Healthcare IT Today

Unlearn partners with pharma sponsors, biotech companies, and academic institutions to streamline and optimize clinical trials, enabling researchers to assess the safety and efficacy of new treatments more quickly and accurately.